A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
In this study, BKM120 will be administered to adult patients with advanced solid tumors whose
disease has progressed despite standard therapy or for whom no standard therapy exists. The
trial will confirm the safety and tolerability and determine the maximum tolerated dose (MTD)
of BKM120 in Japanese patients.